REFERENCES
- Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi M G, Proudfoot A E, Alouani S, Wells T N, Mariani G, Rabin R L, Farber J M, Noonan D M. 1998. HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A. 95: 13153–13158. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Andrews N C, Faller D V. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19: 2499, [PUBMED], [INFOTRIEVE]
- Anthony D C, Miller K M, Fearn S, Townsend M J, Opdenakker G, Wells G M, Clements J M, Chandler S, Gearing A J, Perry V H. 1998. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol. 87: 62–72. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Barchowsky A, Frleta D, Vincenti M P. 2000. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine. 12: 1469–1479. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bonavia R, Bajetto A, Barbero S, Albini A, Noonan D M, Schettini G. 2001. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun. 288: 301–308. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bond M, Baker A H, Newby A C. 1999. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem Biophys Res Commun. 264: 561–567. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Brooks P C, Stromblad S, Sanders L C, von, Schalscha T L, Aimes R T, Stetler-Stevenson W G, Quigley J P, Cheresh D A. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85: 683–693. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 17: 439–444. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Catterall J B, Carrere S, Koshy P J, Degnan B A, Shingleton W D, Brinckerhoff C E, Rutter J, Cawston T E, Rowan A D. 2001. Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum. 44: 2296–2310. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Clifford D B, McArthur J C, Schifitto G, Kieburtz K, McDermott M P, Letendre S, Cohen B A, Marder K, Ellis R J, Marra C M. 2002. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. 59: 1568–1573. [PUBMED], [INFOTRIEVE]
- Conant K, Ahmed U, Schwartz J P, Major E O. 1998a. IFN-gamma inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism. J Neuroimmunol. 88: 39–44. [PUBMED], [INFOTRIEVE]
- Conant K, Garzino-Demo A, Nath A, McArthur J C, Halliday W, Power C, Gallo R C, Major E O. 1998b. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A. 95: 3117–3121. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Conant K, Haughey N, Nath A, St, Hillaire C, Gary D S, Pardo C A, Wahl L M, Bilak M, Milward E, Mattson M P. 2002. Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9. J Neurochem. 82: 885–893. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Conant K, Ma M, Nath A, Major E O. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol. 70: 1384–1389. [PUBMED], [INFOTRIEVE]
- Conant K, McArthur J C, Griffin D E, Sjulson L, Wahl L M, Irani D N. 1999. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol. 46: 391–398. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Dhawan S, Puri R K, Kumar A, Duplan H, Masson J M, Aggarwal B B. 1997. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood. 90: 1535–1544. [PUBMED], [INFOTRIEVE]
- Dumin J A, Dickeson S K, Stricker T P, Bhattacharyya-Pakrasi M, Roby J D, Santoro S A, Parks W C. 2001. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem. 276: 29368–29374. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Epstein L G, Gendelman H E. 1993. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 33: 429–436. [PUBMED], [INFOTRIEVE]
- Fernandez-Patron C, Radomski M W, Davidge S T. 1999. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res. 85: 906–911. [PUBMED], [INFOTRIEVE]
- Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M. 1998. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis. 16: 513–528. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Flora G, Lee Y W, Nath A, Maragos W, Hennig B, Toborek M. 2002. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Med. 2: 71–85. [PUBMED], [INFOTRIEVE]
- Fowlkes J L, Enghild J J, Suzuki K, Nagase H. 1994. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem. 269: 25742–25746. [PUBMED], [INFOTRIEVE]
- Glass J D, Fedor H, Wesselingh S L, McArthur J C. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 38: 755–762. [PUBMED], [INFOTRIEVE]
- Gottschall P E, Yu X. 1995. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 64: 1513–1520. [PUBMED], [INFOTRIEVE]
- Gu Z, Kaul M, Yan B, Kridel S J, Cui J, Strongin A, Smith J W, Liddington R C, Lipton S A. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297: 1186–1190. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hui A, Min W X, Tang J, Cruz T F. 1998. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum. 41: 869–876. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ishihara T, Akiyama K, Kashihara K. 1998. Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized rats. Neuroreport. 9: 3913–3917. [PUBMED], [INFOTRIEVE]
- Johnston J B, Zhang K, Silva C, Shalinsky D R, Conant K, Ni W, Corbett D, Yong V W, Power C. 2001. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol. 49: 230–241. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kumar A, Dhawan S, Mukhopadhyay A, Aggarwal B B. 1999. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett. 462: 140–144. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kumar A, Manna S K, Dhawan S, Aggarwal B B. 1998. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J Immunol. 161: 776–781. [PUBMED], [INFOTRIEVE]
- Lim S P, Garzino-Demo A. 2000. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol. 74: 1632–1640. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lindberg R L, De, Groot C J, Montagne L, Freitag P, van der, Valk P, Kappos L, Leppert D. 2001. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain. 124: 1743–1753. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lorenzl S, Albers D S, Le, Witt P A, Chirichigno J W, Hilgenberg S L, Cudkowicz M E, Beal M F. 2003. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci. 207: 71–76. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Luo Y, Hattori A, Munoz J, Qin Z H, Roth G S. 1999. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Mol Pharmacol. 56: 254–264. [PUBMED], [INFOTRIEVE]
- Ma M, Nath A. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol. 71: 2495–2499. [PUBMED], [INFOTRIEVE]
- Magnuson D S, Knudsen B E, Geiger J D, Brownstone R M, Nath A. 1995. Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol. 37: 373–380. [PUBMED], [INFOTRIEVE]
- Mayne M, Holden C P, Nath A, Geiger J D. 2000. Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol. 164: 6538–6542. [PUBMED], [INFOTRIEVE]
- Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. 1997. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16: 2319–2332. [CROSSREF], [PUBMED], [INFOTRIEVE]
- McCawley L J, Matrisian L M. 2001. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol. 13: 534–540. [CROSSREF], [PUBMED], [INFOTRIEVE]
- McQuibban G A, Butler G S, Gong J H, Bendall L, Power C, Clark-Lewis I, Overall C M. 2001. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 276: 43503–43508. [PUBMED], [INFOTRIEVE]
- Nagase H, Woessner J F, Jr. 1999. Matrix metalloproteinases. J Biol Chem. 274: 21491–21494. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nath A, Maragos W F, Avison M J, Schmitt F A, Berger J R. 2001. Acceleration of HIV dementia with methamphetamine and cocaine. J NeuroVirol. 7: 66–71. [PUBMED], [INFOTRIEVE]
- Ott M, Lovett J L, Mueller L, Verdin E. 1998. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J Immunol. 160: 2872–2880. [PUBMED], [INFOTRIEVE]
- Powell W C, Fingleton B, Wilson C L, Boothby M, Matrisian L M. 1999. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol. 9: 1441–1447. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Power C, Kong P A, Crawford T O, Wesselingh S, Glass J D, McArthur J C, Trapp B D. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol. 34: 339–350. [PUBMED], [INFOTRIEVE]
- Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath M S. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet. 349: 692–695. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rosenberg G A. 2002. Matrix metalloproteinases in neuroinflammation. Glia. 39: 279–291. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rosenberg G A, Navratil M. 1997. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 48: 921–926. [PUBMED], [INFOTRIEVE]
- Sacktor N, Lyles R H, Skolasky R, Kleeberger C, Selnes O A, Miller E N, Becker J T, Cohen B, McArthur J C. 2001. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology. 56: 257–260. [PUBMED], [INFOTRIEVE]
- Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A. 2002. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 62: 1025–1029. [PUBMED], [INFOTRIEVE]
- Sawaya B E, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. 1998. Regulation of TNFalpha and TGFbeta-1 gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol. 87: 33–42. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schmidtmayerova H, Nottet H S, Nuovo G, Raabe T, Flanagan C R, Dubrovsky L, Gendelman H E, Cerami A, Bukrinsky M, Sherry B. 1996. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A. 93: 700–704. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schonbeck U, Mach F, Libby P. 1998. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 161: 3340–3346. [PUBMED], [INFOTRIEVE]
- Shapiro S, Miller A, Lahat N, Sobel E, Lerner A. 2003. Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis. J Neurol Sci. 206: 43–48. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Spencer D C, Price R W. 1992. Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol. 46: 655–693. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Stricker T P, Dumin J A, Dickeson S K, Chung L, Nagase H, Parks W C, Santoro S A. 2001. Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem. 276: 29375–29381. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Sundstrom J B, Mosunjac M, Martinson D E, Bostik P, Donahoe R M, Gravanis M B, Ansari A A. 2001. Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res Hum Retroviruses. 17: 1605–1614. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Van den, Steen P E, Proost P, Wuyts A, Van, Damme J, Opdenakker G. 2000. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 96: 2673–2681. [PUBMED], [INFOTRIEVE]
- Vos C M, Sjulson L, Nath A, McArthur J C, Pardo C A, Rothstein J, Conant K. 2000. Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures. Exp Neurol. 163: 324–330. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Wang Y, Chou J, Jeng C H, Morales M, Wang J Y. 2000. Chronic methamphetamine exposure decreases high affinity uptake function in norepinephrine afferents in the cerebellar cortex: an electrophysiological and electrochemical study. Neuropharmacology. 39: 2112–2123. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Woessner J F, Nagase H. 2000; Matrix metalloproteinases and TIMPs. Oxford; New York, Oxford University Press
- Xiao H, Neuveut C, Tiffany H L, Benkirane M, Rich E A, Murphy P M, Jeang K T. 2000. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A. 97: 11466–11471. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yebra M, Goretzki L, Pfeifer M, Mueller B M. 1999. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res. 250: 231–240. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yu Q, Stamenkovic I. 1999. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13: 35–48. [PUBMED], [INFOTRIEVE]
- Zhang L, Looney D, Taub D, Chang S L, Way D, Witte M H, Graves M C, Fiala M. 1998. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol. 4: 619–626. [PUBMED], [INFOTRIEVE]